NCT01766622 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant Status WITHDRAWN Phase PHASE2
NCT01744821 Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer Status TERMINATED Phase NA
NCT01670799 Availability & Effect of Post-OP Ketorolac on Ovarian, Fallopian Tube or Primary Peritoneal Cancer Status COMPLETED Phase EARLY_PHASE1
NCT01669798 BIBF 1120 in Bevacizumab Resistant, Persistent, or Recurrent Epithelial Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01669226 First-line Intraperitoneal Cisplatin and Etoposide Chemotherapy for Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01666444 VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT01661868 Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer Status WITHDRAWN Phase PHASE2
NCT01659554 A Phase II Combined Modality Protocol of Debulking Surgery With HIPEC Followed by Intraperitoneal Chemotherapy for the Treatment of Recurrent Ovarian, Primary Peritoneal & Fallopian Tube Cancers Status TERMINATED Phase PHASE2
NCT01652079 CRLX101 in Combination With Bevacizumab for Recurrent Ovarian/Tubal/Peritoneal Cancer Status COMPLETED Phase PHASE2
NCT01649336 A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer Status COMPLETED Phase PHASE1
NCT01626014 Interactive Educational Website for Women With Ovarian Cancer & Caregivers Status COMPLETED Phase EARLY_PHASE1
NCT01610869 Low Dose Cyclophosphamide +/-- Nintedanib in Advanced Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01610206 A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer Status COMPLETED Phase PHASE2
NCT01591772 Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer Status COMPLETED Phase N/A
NCT01570582 A Phase IIclinical Trial of Carboplatin and Paclitaxel or Carboplatin and Gemcitabine in Platinum-sensitive, Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer Status UNKNOWN Phase PHASE2
NCT01556841 The Activity of TroVax® Versus Placebo in Relapsed Asymptomatic Ovarian Cancer Status COMPLETED Phase PHASE2